TURKISH VALIDITY AND RELIABILITY STUDY OF THE CORONAVIRUS IMPACT SCALENCT05017506

The Coronavirus Impact Scale Validity and Reliability Study

An observational study of TURKISH VALIDITY AND RELIABILITY STUDY OF THE CORONAVIRUS IMPACT SCALE, run by Ordu University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

This research; The Turkish validity and reliability study of the "Coronavirus Impact Scale" developed by Stoddard and Kaufman (2020) will be conducted in order to bring a new measurement tool to our country. Read more about this study

Who is it for?: Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for: TURKISH VALIDITY AND RELIABILITY STUDY OF THE CORONAVIRUS IMPACT SCALE
What is being tested?: A survey will be made.
How many people: 500 participants
Where: 1 siteTurkey (Türkiye)
Study dates: 1 Sep 2021to 21 Mar 2022
Phase: Observational
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 years and older
All sexes
Healthy volunteers accepted
Adult, Older adult

Study population: Adults presenting to outpatient clinics in the hospital.

Who may be able to join

At least 18 years old,
At least primary school graduate,
Able to communicate verbally and
Persons who agree to participate in the research will be included in the research.

Who cannot join

Psychiatric illness and unable to communicate,
Having a language problem
Persons who do not have the skills to read and understand the questionnaire will be excluded from the research.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site

Ordu Univercity
Ordu, Cumhurıyet Campus, 52000

Other trials in Turkey (Türkiye)

About this study

Official title: Turkish Validity and Reliability Study of The Coronavirus Impact Scale

Read the detailed description

Method: This research was planned as a methodological study. Research Question: Is the "Coronavirus Impact Scale" a valid and reliable measurement tool for Turkish society?

Conditions: TURKISH VALIDITY AND RELIABILITY STUDY OF THE CORONAVIRUS IMPACT SCALE
Being tested: A survey will be made.
Keywords: Coronovirus, Impact, Reliability, Validity, Measuring tool, Nursing.
Medical subject headings: Tooth, Impacted

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

A survey will be made.Other
A survey will be made.

What is being measured

The primary outcome is the main question the study is designed to answer.

Coronavirus Impact Scale
The Coronovirus Impact Scale was developed by Stoddard and Kaufman (2020) to assess the impact of Covid-19 on people. The scale consists of 12 questions. Questions 1-9 in the scale are in 4-point Likert type, 0. There is no change, 1. Mild, 2. Moderate and 3. Severe, and points are taken between 0-3 from these questions. The questions between 10 and 11 on the scale are in a 5-point Likert type and are scored between 0-4 (indicating that from mild symptoms to death). However, the number of first degree family members diagnosed with coronavirus in question 10 and the number of relatives or close friends diagnosed with coronavirus in question 11 are not taken into account in the scale. The 12th question of the scale is open-ended and determines the other aspects that the coronavirus epidemic affects life. A minimum score of 0 and a maximum score of 35 are obtained from the scale, and as the score increases, the degree of exposure of people to the Corona virus increases.
Measured: 8 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1 Sep 202121 Mar 2022

First posted24 Aug 2021
Study start1 Sep 2021
Primary completion1 Jan 2022
Study completion21 Mar 2022

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Publications (1)Papers the sponsor has linked to this study.
Other trials for TURKISH VALIDITY AND RELIABILITY STUDY OF THE CORONAVIRUS IMPACT SCALEStudies of the same condition, open and under way.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Observational
Observational model: Other
Time perspective: Prospective
Enrolment: 500 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT05017506
Sponsor's protocol ID: ayyuzlum3207*
Status last verified: Oct 2022
First submitted: 16 Aug 2021
Last updated: 18 Oct 2022
Results posted: No
Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No
Individual data sharing: No

Publications

Yilmaz Yavuz A, Altinsoy C, Toraman MN, Karabulut Musdal N. The Turkish validity and reliability of the Reward-Based Eating Drive (RED-13) Scale. PLoS One. 2025 Apr 25;20(4):e0322097. doi: 10.1371/journal.pone.0322097. eCollection 2025.
PubMed 40279302

Study at a glance

From the registry record, last updated by the sponsor on 18 Oct 2022. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Turkish Validity and Reliability Study of The Coronavirus Impact Scale
ClinicalTrials.gov ID: NCT05017506
Acronym / sponsor ID: ayyuzlum3207*
Conditions: TURKISH VALIDITY AND RELIABILITY STUDY OF THE CORONAVIRUS IMPACT SCALE
Keywords: Coronovirus, Impact, Reliability, Validity, Measuring tool, Nursing.
Study type: Observational
Recruitment status: Completed
Enrolment: 500 participants (actual)
Lead sponsor: Ordu UniversityUniversity, hospital or other
Study start: 1 Sep 2021 (actual)
Primary completion: 1 Jan 2022 (actual)
Study completion: 21 Mar 2022 (actual)
First posted: 24 Aug 2021 (actual)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Detailed description

Method: This research was planned as a methodological study. Research Question: Is the "Coronavirus Impact Scale" a valid and reliable measurement tool for Turkish society?

Study design

Observational model: Other
Time perspective: Prospective

Who may qualify

Ages: 18 years and older
Sex: All
Healthy volunteers: Accepted
Age groups: Adult, Older adult
Study population: Adults presenting to outpatient clinics in the hospital.

Key inclusion criteria (4 listed)

At least 18 years old,
At least primary school graduate,
Able to communicate verbally and
Persons who agree to participate in the research will be included in the research.

Key exclusion criteria (3 listed)

Psychiatric illness and unable to communicate,
Having a language problem
Persons who do not have the skills to read and understand the questionnaire will be excluded from the research.

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
A survey will be made.A survey will be made.	Other	–

Primary outcome

Coronavirus Impact Scale
Time frame: 8 months
The Coronovirus Impact Scale was developed by Stoddard and Kaufman (2020) to assess the impact of Covid-19 on people. The scale consists of 12 questions. Questions 1-9 in the scale are in 4-point Likert type, 0. There is no change, 1. Mild, 2. Moderate and 3. Severe, and points are taken between 0-3 from these questions. The questions between 10 and 11 on the scale are in a 5-point Likert type and are scored between 0-4 (indicating that from mild symptoms to death). However, the number of first degree family members diagnosed with coronavirus in question 10 and the number of relatives or close friends diagnosed with coronavirus in question 11 are not taken into account in the scale. The 12th question of the scale is open-ended and determines the other aspects that the coronavirus epidemic affects life. A minimum score of 0 and a maximum score of 35 are obtained from the scale, and as the score increases, the degree of exposure of people to the Corona virus increases.

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 18 Oct 2022.
Derived from this study: PubMed 40279302Yilmaz Yavuz A, Altinsoy C, Toraman MN, Karabulut Musdal N. The Turkish validity and reliability of the Reward-Based Eating Drive (RED-13) Scale. PLoS One. 2025 Apr 25;20(4):e0322097. doi: 10.1371/journal.pone.0322097. eCollection 2025.
Stoddard J, Kaufman J. (2020). Coronavirus Impact Scale.Link provided by the sponsor.
Individual participant dataSharing planned: No

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

The record lists no contact. Use the official record to reach the sponsor.

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

An observational study of TURKISH VALIDITY AND RELIABILITY STUDY OF THE CORONAVIRUS IMPACT SCALE, run by Ordu University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Coronavirus Impact Scale (time frame: 8 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05017506, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Oct 2022.